|
⚲
|
| Keyboard |
| Tekmira Pharmaceuticals Corp | |
|---|---|
| Ticker | ABUS |
| CIK # | 0001447028 |
| CUSIP | 03879J100 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 100-8900 Glenlyon Parkway, Burnaby, BC V5J 5J8 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Arbutus Biopharma Corp | 2021-12-30 | 15.0 M | Exemption: 506(b) · Duration: One year or less · Revenue: $5,000,001 - $25,000,000 |
| Tekmira Pharmaceuticals Corp | 2009-03-23 | Exemption: 506 · Remaining: Indefinite · Duration: One year or less · Revenue: $5,000,001 - $25,000,000 |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001447028] | 10-K | |
| [0001447028] | 10-Q | |
| [0001447028] | 3 | |
| [0001447028] | 4 | |
| [0001447028] | 6-K | |
| [0001447028] | 8-K | |
| [0001447028] | D | |
| [0001447028] | SC 13D | |
| [0001447028] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Nguyen Tuan
Common Shares
|
2026-02-02 | Grant | 73,500 | $0.00 | |
|
Nguyen Tuan
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 188,400 | $0.00 | |
|
Androski Lindsay
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 71,700 | $0.00 | |
|
Androski Lindsay
Common Shares
|
2026-02-02 | Grant | 28,000 | $0.00 | |
|
Sawhney Roger
Stock Option (Right to Buy) · derivative
|
2025-08-04 | Grant | 157,600 | $0.00 | |
|
Stock Option (Right to Buy) · derivative
|
2025-03-31 | Grant | 750,000 | $0.00 | |
|
Nguyen Tuan
Stock Option (Right to Buy) · derivative
|
2025-03-31 | Grant | 750,000 | $0.00 | |
|
Androski Lindsay
Stock Option (Right to Buy) · derivative
|
2025-03-18 | Grant | 310,422 | $0.00 | |
|
Beardsley Robert A
Stock Option (Right to Buy) · derivative
|
2025-03-18 | Grant | 157,600 | $0.00 | |
|
Hasija Anuj
Stock Option (Right to Buy) · derivative
|
2025-03-18 | Grant | 157,600 | $0.00 | |
|
Sims Karen
Common Shares
|
2025-02-14 | Grant | 49,300 | $0.00 | |
|
McElhaugh Michael J
Stock Option (Right to Buy) · derivative
|
2025-02-14 | Grant | 718,800 | $0.00 | |
|
Hastings David C
Stock Option (Right to Buy) · derivative
|
2025-02-14 | Grant | 365,800 | $0.00 | |
|
Sims Karen
Stock Option (Right to Buy) · derivative
|
2025-02-14 | Grant | 200,300 | $0.00 | |
|
Naftzger J Christopher
Common Shares
|
2025-02-14 | Grant | 54,300 | $0.00 | |
|
McElhaugh Michael J
Common Shares
|
2025-02-14 | Grant | 177,000 | $0.00 | |
|
Hastings David C
Common Shares
|
2025-02-14 | Grant | 90,100 | $0.00 | |
|
Naftzger J Christopher
Stock Option (Right to Buy) · derivative
|
2025-02-14 | Grant | 220,300 | $0.00 | |
|
McElhaugh Michael J
Common Shares
|
2025-02-04 | Sell | 23,790 | $3.28 | 78,031 |
|
Hastings David C
Common Shares
|
2025-02-04 | Sell | 22,183 | $3.28 | 72,760 |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 170 | 140,091,150 |
| 2025-12-31 | 176 | 125,698,055 |
| 2025-09-30 | 170 | 121,583,994 |
| 2025-06-30 | 165 | 119,827,030 |
| 2025-03-31 | 171 | 113,291,997 |
| 2024-12-31 | 156 | 105,407,344 |
| 2024-09-30 | 146 | 103,961,614 |
| 2024-06-30 | 133 | 100,515,755 |
| 2024-03-31 | 123 | 106,432,921 |
| 2023-12-31 | 113 | 88,682,755 |
| 2023-09-30 | 102 | 76,079,654 |
| 2023-06-30 | 114 | 67,325,416 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Ledgewood Wealth Advisors LLC | [2026-06-30] | SOLE | 0 | 278,436 |
| Eastern Bank | [2026-06-30] | SOLE | 5,000 | 5,000 |
| Harbor Investment Advisory LLC | [2026-06-30] | SOLE | 500 | 500 |
| Gamma Investing LLC | [2026-06-30] | DFND | 228 | 228 | Prev | Page 1 | Next |